» Articles » PMID: 28085072

Incidence and Simple Prediction Model of Hyperuricemia for Urban Han Chinese Adults: A Prospective Cohort Study

Overview
Publisher MDPI
Date 2017 Jan 14
PMID 28085072
Citations 21
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Hyperuricemia (HUA) contributes to gout and many other diseases. Many hyperuricemia-related risk factors have been discovered, which provided the possibility for building the hyperuricemia prediction model. In this study we aimed to explore the incidence of hyperuricemia and develop hyperuricemia prediction models based on the routine biomarkers for both males and females in urban Han Chinese adults.

Methods: A cohort of 58,542 members of the urban population (34,980 males and 23,562 females) aged 20-80 years old, free of hyperuricemia at baseline examination, was followed up for a median 2.5 years. The Cox proportional hazards regression model was used to develop gender-specific prediction models. Harrell's C-statistics was used to evaluate the discrimination ability of the models, and the 10-fold cross-validation was used to validate the models.

Results: In 7139 subjects (5585 males and 1554 females), hyperuricemia occurred during a median of 2.5 years of follow-up, leading to a total incidence density of 49.63/1000 person years (64.62/1000 person years for males and 27.12/1000 person years for females). The predictors of hyperuricemia were age, body mass index (BMI) systolic blood pressure, serum uric acid for males, and BMI, systolic blood pressure, serum uric acid, triglycerides for females. The models' C statistics were 0.783 (95% confidence interval (CI), 0.779-0.786) for males and 0.784 (95% CI, 0.778-0.789) for females. After 10-fold cross-validation, the C statistics were still steady, with 0.782 for males and 0.783 for females.

Conclusions: In this study, gender-specific prediction models for hyperuricemia for urban Han Chinese adults were developed and performed well.

Citing Articles

One-Year Risk Prediction of Elevated Serum Uric Acid Levels in Older Adults: A Longitudinal Cohort Study.

Zhang D, Xu X, Ye Z, Zhang Z, Xiao J Clin Interv Aging. 2024; 19:1951-1964.

PMID: 39605933 PMC: 11600923. DOI: 10.2147/CIA.S476806.


Study on risk factor analysis and model prediction of hyperuricemia in different populations.

Hou K, Shi Z, Ge X, Song X, Yu C, Su Z Front Nutr. 2024; 11:1417209.

PMID: 39469332 PMC: 11513274. DOI: 10.3389/fnut.2024.1417209.


Elevated blood pressure and hyperuricemia risk: a retrospective cohort study from Wuhu, China.

Fang Y, Tavengana G, Wu H, Mei W, Jiang C, Wang C Sci Rep. 2024; 14(1):19994.

PMID: 39198626 PMC: 11358373. DOI: 10.1038/s41598-024-71087-x.


Multimodal Machine Learning-Based Marker Enables Early Detection and Prognosis Prediction for Hyperuricemia.

Zeng L, Ma P, Li Z, Liang S, Wu C, Hong C Adv Sci (Weinh). 2024; 11(34):e2404047.

PMID: 38976552 PMC: 11425915. DOI: 10.1002/advs.202404047.


Association between low-density lipoprotein cholesterol levels and serum uric acid to serum creatinine ratio in Chinese male gout patients.

Shao Q, Chi J, Che K, Zhou Y, Huang Y, Wang Y Sci Rep. 2024; 14(1):10121.

PMID: 38698027 PMC: 11066108. DOI: 10.1038/s41598-024-59992-7.


References
1.
Liote F . Hyperuricemia and gout. Curr Rheumatol Rep. 2003; 5(3):227-34. DOI: 10.1007/s11926-003-0072-y. View

2.
Nakanishi N, Tatara K, Nakamura K, Suzuki K . Risk factors for the incidence of hyperuricaemia: a 6-year longitudinal study of middle-aged Japanese men. Int J Epidemiol. 1999; 28(5):888-93. DOI: 10.1093/ije/28.5.888. View

3.
Yu S, Yang H, Guo X, Zhang X, Zhou Y, Ou Q . Prevalence of hyperuricemia and its correlates in rural Northeast Chinese population: from lifestyle risk factors to metabolic comorbidities. Clin Rheumatol. 2015; 35(5):1207-15. DOI: 10.1007/s10067-015-3051-6. View

4.
Chang C, Chen Y, Chuang Y, Liao S, Lin C, Tang Y . Relationship between hyperuricemia (HUC) and metabolic syndrome (MS) in institutionalized elderly men. Arch Gerontol Geriatr. 2009; 49 Suppl 2:S46-9. DOI: 10.1016/S0167-4943(09)70013-5. View

5.
Baker J, Krishnan E, Chen L, Schumacher H . Serum uric acid and cardiovascular disease: recent developments, and where do they leave us?. Am J Med. 2005; 118(8):816-26. DOI: 10.1016/j.amjmed.2005.03.043. View